Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 80.20
-0.80 (-0.99%)
Aug 4, 2026, 3:56 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 362.75 million as of August 4, 2026.
Market Cap
362.75M
Enterprise Value
188.70M
Revenue
28.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
80.20
ChartMarket Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 362.75M, an increase of 94.61%. That is a compound annual growth rate of 139.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 362.75M | 64.97% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 2.08B |
| Circio Holding ASA | 1.95B |
| Nykode Therapeutics AS | 1.10B |
| ArcticZymes Technologies ASA | 1.00B |
| Zelluna ASA | 682.40M |
| Lytix Biopharma ASA | 669.03M |
| SoftOx Solutions AS | 236.24M |
| Aqua Bio Technology ASA | 74.18M |